| Title : Safety and pharmacokinetic profiles of MGS0274 besylate (TS-134), a novel metabotropic glutamate 2\/3 receptor agonist prodrug, in healthy subjects - Watanabe_2020_Br.J.Clin.Pharmacol_86_2286 |
| Author(s) : Watanabe M , Marcy B , Kinoshita K , Fukasawa M , Hikichi H , Chaki S , Okuyama S , Gevorkyan H , Yoshida S |
| Ref : British Journal of Clinical Pharmacology , 86 :2286 , 2020 |
| Abstract : Watanabe_2020_Br.J.Clin.Pharmacol_86_2286 |
| ESTHER : Watanabe_2020_Br.J.Clin.Pharmacol_86_2286 |
| PubMedSearch : Watanabe_2020_Br.J.Clin.Pharmacol_86_2286 |
| PubMedID: 32353162 |
Watanabe M, Marcy B, Kinoshita K, Fukasawa M, Hikichi H, Chaki S, Okuyama S, Gevorkyan H, Yoshida S (2020)
Safety and pharmacokinetic profiles of MGS0274 besylate (TS-134), a novel metabotropic glutamate 2\/3 receptor agonist prodrug, in healthy subjects
British Journal of Clinical Pharmacology
86 :2286
Watanabe M, Marcy B, Kinoshita K, Fukasawa M, Hikichi H, Chaki S, Okuyama S, Gevorkyan H, Yoshida S (2020)
British Journal of Clinical Pharmacology
86 :2286